Drug information for DORIBAX

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; IV (INFUSION) 250MG/VIAL Prescription   DORIPENEM doripenem JANSSEN PHARMS 22106
2012-01-31 Label

2009-04-23 Label

2009-04-23 Label

2009-04-21 Letter

2009-04-21 Letter

2009-02-12 Label

2008-07-22 Summary Review

2008-03-14 Review

2007-10-22 Letter

2007-10-15 Label
INJECTABLE; IV (INFUSION) 500MG/VIAL Prescription  (Reference Drug) DORIPENEM doripenem JANSSEN PHARMS   "

Drug Adverse Effects information for DORIBAX

Role code Indications Reaction # Reports
PS ESCHERICHIA INFECTION ANAPHYLACTIC SHOCK 1
PS PNEUMONIA ANURIA 1
PS PNEUMONIA BLOOD PRESSURE INCREASED 1
PS PNEUMONIA BRADYCARDIA 1
PS PNEUMONIA OXYGEN SATURATION DECREASED 2
PS PNEUMONIA Q FEVER 1
PS PRODUCT USED FOR UNKNOWN INDICATION BLOOD PRESSURE INCREASED 1
PS PRODUCT USED FOR UNKNOWN INDICATION OXYGEN SATURATION DECREASED 1
PS PRODUCT USED FOR UNKNOWN INDICATION Q FEVER 1
PS SEPSIS CONVULSION 4
SS PNEUMONIA ANURIA 1
SS PNEUMONIA BRADYCARDIA 1
SS PNEUMONIA OXYGEN SATURATION DECREASED 1
SS PRODUCT USED FOR UNKNOWN INDICATION BRONCHOSPASM 8
SS PRODUCT USED FOR UNKNOWN INDICATION DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8
C DIURETIC THERAPY INTERSTITIAL LUNG DISEASE 1
C HEPATITIS C ASTHENIA 2
C HEPATITIS C BLOOD GLUCOSE INCREASED 2
C HEPATITIS C CHILLS 2
C HEPATITIS C CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2
C HEPATITIS C CONSTIPATION 2
C HEPATITIS C COUGH 2
C HEPATITIS C CREPITATIONS 2
C HEPATITIS C DECREASED APPETITE 2
C HEPATITIS C DEHYDRATION 2
C HEPATITIS C DIZZINESS 2
C HEPATITIS C DYSPNOEA 2
C HEPATITIS C GAIT DISTURBANCE 2
C HEPATITIS C NAUSEA 2
C HEPATITIS C PLATELET COUNT DECREASED 2
C HEPATITIS C PNEUMONIA 2
C HEPATITIS C RESPIRATORY DISTRESS 2
C HEPATITIS C VOMITING 2
C POLYURIA BLOOD UREA INCREASED 1
C POLYURIA INTERSTITIAL LUNG DISEASE 1
C POLYURIA PULMONARY ALVEOLAR HAEMORRHAGE 1
C PULMONARY ARTERIAL HYPERTENSION DEVICE RELATED INFECTION 2
C PULMONARY ARTERIAL HYPERTENSION PYREXIA 2
Ads by Google